ROOT, an object oriented data analysis framework

ROOT is an object-oriented framework aimed at solving the data analysis challenges of high-energy physics. Here we discuss the main components of the framework. We begin with an overview describing the framework's organization, the interpreter CINT, its automatic interface to the compiler and linker ACLiC, and an example of a first interactive session. The subsequent sections cover histogramming and fitting. Then, ROOT's solution to storing and retrieving HEP data, building and managing of ROOT files, and designing ROOT trees. Followed by a description of the collection classes, the GUI classes, how to add your own classes to ROOT, and PROOF, ROOT's parallel processing facility

Physicochemical Aspects of Metal Nanoparticle Preparation

Physicochemical properties, including optical properties or catalytic activity, and biological properties of metal nanoparticles are considerably influenced by their diameter. Therefore, a tailored synthesis of metal nanoparticles represents a key topic in the field of nanotechnology, and the number of research papers, concerning this topic, has been annually growing with an arithmetic progression. Metal nanoparticles are most frequently prepared via chemical reduction of metals in ionic form from their solutions. Using this synthetic approach, tailored parameters of the particles can be achieved via the adjustment of numerous factors: difference of potentials of the metal redox system and the reducing agent redox system, pH of the reaction mixture, and its temperature. The influence of these three factors on the diameter of the prepared metal nanoparticles will be discussed in the following chapter with respect to general laws and based on numerous examples from research practice

The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?

Sepsis remains the leading cause of death in most intensive care units. Advances in understanding the immune response to sepsis provide the opportunity to develop more effective therapies. The immune response in sepsis can be characterized by a cytokine-mediated hyper-inflammatory phase, which most patients survive, and a subsequent immune-suppressive phase. Patients fail to eradicate invading pathogens and are susceptible to opportunistic organisms in the hypo-inflammatory phase. Many mechanisms are responsible for sepsis-induced immuno-suppression, including apoptotic depletion of immune cells, increased T regulatory and myeloid-derived suppressor cells, and cellular exhaustion. Currently in clinical trial for sepsis are granulocyte macrophage colony stimulating factor and interferon gamma, immune-therapeutic agents that boost patient immunity. Immuno-adjuvants with promise in clinically relevant animal models of sepsis include anti-programmed cell death-1 and interleukin-7. The future of immune therapy in sepsis will necessitate identification of the immunologic phase using clinical and laboratory parameters as well as biomarkers of innate and adaptive immunity